Celgene, Novartis Chastised Over Cancer Drug Claims
The U.S. Food and Drug Administration chastised Celgene Corp. and Novartis AG in letters released Wednesday for distributing potentially misleading claims in marketing materials that could affect doctors' decisions for prescribing...To view the full article, register now.
Already a subscriber? Click here to view full article